AVEO PHARMACEUTICALS INC (AVEO)
US0535883070 - Common Stock
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer –
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of...
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib...
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Phase 3 Registrational Trial Seeks to Improve Survival Outcomes in Underserved HPV-negative R/M Head and Neck Cancer Patient PopulationTrial Launch Follows...
LG Chem Completes Acquisition of AVEO Oncology
AVEO to Become the U.S. Foundation for LG Chem Life Sciences’ Oncology Division
LG Chem Completes Acquisition of AVEO Oncology
AVEO to Become the U.S. Foundation for LG Chem Life Sciences’ Oncology Division...
Aveo Oncology shareholders approve acquisition by LG Chem (NASDAQ:AVEO)
Aveo Oncology (AVEO) shareholders have approved the company's proposed acquisition by LG Chem (LGCLF).In October 2022, LG Chem (LGCLF) proposed to acquire Aveo Oncology (AVEO) for...
AVEO Oncology Stockholders Approve Acquisition by LG Chem
AVEO Oncology Stockholders Approve Acquisition by LG Chem
BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed...
AVEO Oncology Reminds Stockholders to Vote “FOR” All-Cash Transaction with LG Chem in advance of the Special Meeting of Stockholders
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend that AVEO Stockholders Vote “FOR” the Transaction...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OFIX, AAWW, AVEO, MYOV
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
AVEO Oncology Reports Third Quarter 2022 Financial Results
– Total Q3 2022 Net Revenue of $30.4 million, including $30.2 million of FOTIVDA® (tivozanib) U.S. Net Product Revenue – – Announced entering a definitive...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVEO, PEBO, LMST, MYOV
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LFG, CLR, AVEO, AKUS
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Investigates AVEO Pharmaceuticals, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AVEO Pharmaceuticals,...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKUS, AVEO, LFG, CLR
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote
Zovio (ZVO) stock is rocketing higher on Tuesday as investors prepare for an incredibly important vote next week!
Shareholder Alert: Ademi LLP investigates whether AVEO Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with LG Chem
/PRNewswire/ -- Ademi LLP is investigating AVEO (NASDAQ: AVEO) for possible breaches of fiduciary duty and other violations of law in its transaction with LG...